OBJECTIVE: To develop and examine the psychometric properties of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition (CY-BOCS-II) in children and adolescents with obsessive-compulsive disorder (OCD). METHOD: Youth with OCD (N = 102; age range 7-17 years), who were seeking treatment from 1 of 2 specialty OCD treatment centers, participated in the study. The CY-BOCS-II was administered at an initial assessment, and measures of OCD symptom severity, anxiety and depressive symptoms, behavioral and emotional problems, and global functioning were administered. Inter-rater and test-retest reliabilities were assessed on a subsample of participants (n = 50 and n = 31, respectively) approximately 1 week after intial assessment. RESULTS: The CY-BOCS-II demonstrated moderate-to-strong internal consistency (α = 0.75-0.88) and excellent inter-rater (intraclass correlation coefficient = 0.86-0.92) and test-retest (intraclass correlation coefficient = 0.95-0.98) reliabilities across all scales. Construct validity was supported by strong correlations with clinician-rated measures of OCD symptom severity and moderate correlations with measures of anxiety symptoms. Exploratory factor analysis showed a 2-factor structure, which was generally inconsistent with its adult counterpart, the Yale-Brown Obsessive-Compulsive Scale Second Edition. CONCLUSION: Initial findings support the CY-BOCS-II as a reliable and valid measure of obsessive-compulsive symptoms in youth.
OBJECTIVE: To develop and examine the psychometric properties of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition (CY-BOCS-II) in children and adolescents with obsessive-compulsive disorder (OCD). METHOD: Youth with OCD (N = 102; age range 7-17 years), who were seeking treatment from 1 of 2 specialty OCD treatment centers, participated in the study. The CY-BOCS-II was administered at an initial assessment, and measures of OCD symptom severity, anxiety and depressive symptoms, behavioral and emotional problems, and global functioning were administered. Inter-rater and test-retest reliabilities were assessed on a subsample of participants (n = 50 and n = 31, respectively) approximately 1 week after intial assessment. RESULTS: The CY-BOCS-II demonstrated moderate-to-strong internal consistency (α = 0.75-0.88) and excellent inter-rater (intraclass correlation coefficient = 0.86-0.92) and test-retest (intraclass correlation coefficient = 0.95-0.98) reliabilities across all scales. Construct validity was supported by strong correlations with clinician-rated measures of OCD symptom severity and moderate correlations with measures of anxiety symptoms. Exploratory factor analysis showed a 2-factor structure, which was generally inconsistent with its adult counterpart, the Yale-Brown Obsessive-Compulsive Scale Second Edition. CONCLUSION: Initial findings support the CY-BOCS-II as a reliable and valid measure of obsessive-compulsive symptoms in youth.
Authors: Alessandro De Nadai; Prianka S Nagpal; John Piacentini; Tara S Peris; Gary R Geffken; Daniel A Geller; Tanya K Murphy; Eric A Storch; Adam B Lewin Journal: Psychiatry Res Date: 2015-04-06 Impact factor: 3.222
Authors: Eric A Storch; Adam B Lewin; Michael J Larson; Gary R Geffken; Tanya K Murphy; Daniel A Geller Journal: Psychiatry Res Date: 2012-02-25 Impact factor: 3.222
Authors: B Birmaher; S Khetarpal; D Brent; M Cully; L Balach; J Kaufman; S M Neer Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-04 Impact factor: 8.829
Authors: Joseph F McGuire; Eric A Storch; Adam B Lewin; Lawrence H Price; Steven A Rasmussen; Wayne K Goodman Journal: Compr Psychiatry Date: 2011-05-06 Impact factor: 3.735
Authors: Anna M Jones; Alessandro S De Nadai; Elysse B Arnold; Joseph F McGuire; Adam B Lewin; Tanya K Murphy; Eric A Storch Journal: Child Psychiatry Hum Dev Date: 2013-02
Authors: Tara S Peris; R Lindsey Bergman; Joan R Asarnow; Audra Langley; James T McCracken; John Piacentini Journal: J Clin Child Adolesc Psychol Date: 2010
Authors: Eric Hollander; Lorrin M Koran; Wayne K Goodman; John H Greist; Philip T Ninan; Haichen Yang; David Li; Luigi M Barbato Journal: J Clin Psychiatry Date: 2003-06 Impact factor: 4.384
Authors: Dean McKay; John Piacentini; Scott Greisberg; Flemming Graae; Margaret Jaffer; Jillian Miller; Fugen Neziroglu; Jose A Yaryura-Tobias Journal: Psychol Assess Date: 2003-12
Authors: Amitai Abramovitch; Jonathan S Abramowitz; Dean McKay; Heining Cham; Kennedy S Anderson; Lara Farrell; Daniel A Geller; Gregory L Hanna; Sharna Mathieu; Joseph F McGuire; David R Rosenberg; S Evelyn Stewart; Eric A Storch; Sabine Wilhelm Journal: J Anxiety Disord Date: 2022-01-15
Authors: Gregory S Vogt; Michelle Avendaño-Ortega; Sophie C Schneider; Wayne K Goodman; Eric A Storch Journal: J Psychiatr Pract Date: 2022-07-01 Impact factor: 1.841
Authors: Amitai Abramovitch; Jonathan S Abramowitz; Dean McKay; Heining Cham; Kennedy S Anderson; Lara J Farrell; Daniel A Geller; Gregory L Hanna; Sharna Mathieu; Joseph F McGuire; David R Rosenberg; S Evelyn Stewart; Eric A Storch; Sabine Wilhelm Journal: J Affect Disord Date: 2022-06-11 Impact factor: 6.533
Authors: Caroline Gromark; Eva Hesselmark; Ida Gebel Djupedal; Maria Silverberg; AnnaCarin Horne; Robert A Harris; Eva Serlachius; David Mataix-Cols Journal: Child Psychiatry Hum Dev Date: 2021-02-09
Authors: Clara Westwell-Roper; John R Best; Dean Elbe; Megan MacFadden; Susan Baer; Lori Tucker; Antony Au; Zainab Naqqash; Boyee Lin; Cynthia Lu; S Evelyn Stewart Journal: BMJ Open Date: 2022-01-31 Impact factor: 2.692